Resveratrol has been shown to suppress the pro-atherosclerotic effects of hyperglycemia on ECs by limiting ET-1 and E-selectin mRNA expression and boosting endothelial NO synthase via eNOS/NO signaling, which is triggered by SIRT1 activation [129]. This evidence concerns the gene NOS3 and Hyperglycemia.